FIELD: pharmaceutics; medicine.
SUBSTANCE: invention relates to pharmaceutics and medicine, namely to use of a peptide of formula Met-Glu-His-Phe-Pro-Gly-Pro (Semax) as a therapeutic agent for anosmia developing with underlying COVID-19.
EFFECT: more effective treatment of the consequences of COVID-19 in humans, namely anosmia.
1 cl, 3 dwg, 7 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
USING METHOD FOR PREPARING CONDITIONED MEDIUM HAVING REGENERATIVE POTENTIAL FOR INTRANASAL ADMINISTRATION IN TREATING CHRONIC POST-VIRAL OLFACTORY DISORDERS | 2023 |
|
RU2816357C1 |
METHOD FOR PHYSICAL THERAPY OF ANOSMIA AFTER CORONAVIRUS INFECTION | 2021 |
|
RU2751823C1 |
METHOD FOR ASSESSING THE THRESHOLD OF OLFACTION IN CHILDREN | 2021 |
|
RU2770290C1 |
METHOD FOR TREATING DYSOSMIA CAUSED BY CORONAVIRUS INFECTION | 2021 |
|
RU2791808C2 |
METHOD OF TREATING PATIENTS WITH OLFACTORY DYSFUNCTION IN ATROPHIC RHINITIS | 2019 |
|
RU2713786C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARKINSONIAN DISEASE AND ESSENTIAL TREMOR | 2011 |
|
RU2467697C1 |
DIAGNOSTIC TECHNIQUE FOR PARKINSON DISEASE IN PATIENTS WITH OLFACTORY DYSFUNCTION | 2011 |
|
RU2478209C1 |
USE OF MET-GLU-HIS-PHE-PRO-GLY-PRO (SEMAX) PEPTIDE TO ACHIEVE ADAPTOGENIC EFFECT DURING SHORT-TERM PHYSICAL ACTIVITY | 2023 |
|
RU2813470C1 |
METHOD FOR REHABILITATION OF PATIENTS WITH OLFACTORY DISORDERS | 2022 |
|
RU2806234C1 |
APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
Authors
Dates
2024-04-02—Published
2023-09-29—Filed